During the past decade, the First People's Hospital of Foshan conducted 58 clinical trials. In the 10-year time frame, 58 clinical trials started and 4 clinical trials were completed, i.e. on average, 6.9% percent of trials that started reached the finish line to date. In the past 5 years, 40 clinical trials started and 4 clinical trials were completed. i.e. 10% of trials that started reached the finish line.

Out of the total clinical trials conducted in "the First People's Hospital of Foshan" #1 sponsor was "Sun Yat-sen University" with 11 trials, followed by "Nanfang Hospital of Southern Medical University" with 7 trials sponsored, "Hoffmann-La Roche" with 6 trials sponsored, "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University" with 4 trials sponsored and "Shanghai Junshi Bioscience Co., Ltd." with 4 trials sponsored. Other sponsors include 38 different institutions and companies that sponsored additional 39 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "the First People's Hospital of Foshan" #1 collaborator was "First People's Hospital of Foshan" with 11 trials as a collaborator, "Affiliated Cancer Hospital & Institute of Guangzhou Medical University" with 4 trials as a collaborator, "Nanfang Hospital of Southern Medical University" with 4 trials as a collaborator, "First Affiliated Hospital, Sun Yat-Sen University" with 3 trials as a collaborator and "West China Hospital" with 3 trials as a collaborator. Other collaborators include 179 different institutions and companies that were collaborators in the rest 169 trials.

According to Clinical.Site data, the most researched conditions in "the First People's Hospital of Foshan" are "Nasopharyngeal Carcinoma" (4 trials), "Breast Cancer" (3 trials), "Crohn's Disease" (3 trials), "Hepatitis B, Chronic" (3 trials) and "Chronic Hepatitis B" (2 trials). Many other conditions were trialed in "the First People's Hospital of Foshan" in a lesser frequency.

Most popular intervention types in "the First People's Hospital of Foshan" are "Drug" (60 trials), "Other" (9 trials), "Procedure" (9 trials), "Radiation" (8 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Cisplatin" (4 trials), "Capecitabine" (3 trials), "Gemcitabine" (3 trials) and "Tislelizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "the First People's Hospital of Foshan" are 63 trials for "All" genders, 10 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "the First People's Hospital of Foshan". 2 are not yet recruiting, 28 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in the First People's Hospital of Foshan, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in the First People's Hospital of Foshan, 1 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 8 trials that are defined as “Not Applicable".